¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"central and lateral intermediate substance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • spongy substance
    ÇØ¸éÁú
  • subacrosomal substance
    ÷´Üü¹Ø¹°Áú
  • substance withdrawal
    ¹°Áú±Ý´Ü
  • threshold substance
    ¹®Åΰª¹°Áú, ¿ªÄ¡¹°Áú
  • toxic substance
    µ¶¼º¹°Áú
  • transforming substance
    ÇüÁúÀüȯÀ¯È¿¹°Áú
  • visual substance
    ½Ã°¢¹°Áú
  • volatile substance
    Èֹ߹°Áú
  • white substance
    ¹é»öÁú
  • zymoplastic substance
    ÀÀÇ÷ÃËÁø¹°Áú
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • toxic substance
    À¯µ¶¼ººÐ(êóÔ¸à÷ÝÂ), µ¶¹°(Ô¸Úª), µ¶¼º¹°Áú.
  • transforming substance
    ÇüÁúÀüȯ À¯È¿¹°Áú
  • visual substance
    ½Ã°¢¹°Áú(¡­Úªòõ).
  • volatile substance
    ÈÖ¹ß(¼º)¹°Áú(¡­Úªòõ).
  • white substance
    ¹é»öÁú
  • zymoplastic substance
    ÀÀÇ÷ÃËÁø¹°Áú(ëêúìõµòäÚªòõ).
  • ala of central lobule
    Á߽ɼҿ±³¯°³
  • anterolateral central arteries anterolateral thalamostriate
    ¾Õ°¡ÂÊÁ߽ɵ¿¸Æ ¾Õ°¡ÂʽûóÁÙ¹«
  • anteromedial central arteries
    ¾Õ¾ÈÂÊÁ߽ɵ¿¸Æ
  • anteromedial central branches
    ¾Õ¾ÈÂÊÁ߽ɰ¡Áö
  • artery of central sulcus
    Á߽ɰí¶ûµ¿¸Æ
  • central
    Áß½É, ÁßÃß
  • central absence
    Á߽ɰῩÁõ
  • central action
    ÁßÃßÀÛ¿ë(ñéõÒíÂéÄ).
  • central amaurosis
    ÁßÃß¼ºÈæ¾Ï½Ã(ñéõÒàõýÙÒ®î¡).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • Lateral semicircular canal
    °¡ÂÊ¹Ý°í¸®»À°ü
    [¿¾ ¿ë¾î] ¿ÜÃø°ñ¹Ý±Ô°ü
  • Lateral osseous ampulla
    °¡ÂÊ¹Ý°í¸®»À°üÆØ´ë
    [¿¾ ¿ë¾î] ¿ÜÃø°ñÆØ´ëºÎ
  • Lateral meniscus
    °¡ÂʹݴÞ
    [¿¾ ¿ë¾î] ¿ÜÃø¹Ý¿ù
  • Lateral cricoarytenoid m.
    °¡ÂʹÝÁö¸ð»Ô±Ù
    [¿¾ ¿ë¾î] ¿ÜÃøÀ±»óÇÇ¿­±Ù
  • Lateral calcaneal branches
    °¡Âʹ߲ÞÄ¡°¡Áö
    [¿¾ ¿ë¾î] ¿ÜÃøÁ¾°ñÁö
  • Lateral dorsal cutaneous nerve
    °¡ÂʹߵîÇǺνŰæ
    [¿¾ ¿ë¾î] ¿ÜÃøÁ·¹èÇǽŰæ
  • Lateral margin of foot
    °¡Âʹ߸𼭸®
    [¿¾ ¿ë¾î] ¿ÜÃøÁ·¿¬
  • Lateral tarsal artery
    °¡Âʹ߸ñµ¿¸Æ
    [¿¾ ¿ë¾î] ¿ÜÃøÁ·±Ùµ¿¸Æ
  • Lateral plantar artery
    °¡Âʹ߹ٴڵ¿¸Æ
    [¿¾ ¿ë¾î] ¿ÜÃøÁ·Ã´µ¿¸Æ
  • Lateral plantar nerve
    °¡Âʹ߹ٴڽŰæ
    [¿¾ ¿ë¾î] ¿ÜÃøÁ·Ã´½Å°æ
  • Lateral vesicular lymph nodes
    °¡Âʹ汤¸²ÇÁÀý
    [¿¾ ¿ë¾î] ¿ÜÃø¹æ±¤ÀÓÆÄÀý
  • Lateral thyrohyoid ligament
    °¡ÂʹæÆÐ¸ñ»ÔÀδë
    [¿¾ ¿ë¾î] ¿ÜÃø°©»ó¼³°ñÀδë
  • Lateral umbilical fold
    °¡Âʹè²ÅÁÖ¸§
    [¿¾ ¿ë¾î] ¿ÜÃøÁ¦ÁÖ¸§
  • Lateral wall
    °¡Âʺ®
    [¿¾ ¿ë¾î] ¾È¿Í¿ÜÃøº®
  • Lateral malleolus
    °¡Âʺ¹»ç
    [¿¾ ¿ë¾î] ¿Ü°ú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 15
FRS Fellow of the Royal Society; ferredoxin-reducing substance; first rank symptom; furosemide
GSS gamete-shedding substance; General Social Survey; Gerstmann-Straussler-Scheinker [disease]
IAS immunosuppressive acidic substance; infant apnea syndrome; insulin autoimmune syndrome; interatrial ...
I-sub inhibitor substance
LASS labile aggregation stimulating substance
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 15
CCD Central Core Disease
CMCT Central Motor Conduction Time
CPG Central Pattern Generator
CPM Central Pontine Myelinolysis
CPU Central Processing Unit
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • lateral border movement
    Ãø¹æ ÇÑ°è ¿îµ¿
  • lateral border of tibia
    °ñ°£ ¿¬
  • lateral brainstem
    ¿ÜÃø ³ú°£
  • lateral branch of posterior intercostal artery
    ÈÄ´Á°£ µ¿¸ÆÀÇ ¿ÜÃø Áö
  • lateral bursa of gastrocnemius muscle
    ºñº¹±Ù ¿ÜÃø °Ç Çϳ¶
  • lateral canal
    Ãø¹æ °ü
    ÁÖÄ¡±Ù°ü¿¡¼­ºÎÅÍ Á÷°¢¿¡ °¡±õ°Ô ³ª´©¾îÁ®¼­ Ä¡±ÙÀÇ ¿Ü¸é¿¡ °³±¸ÇÏ´Â °¡´Â °ü. ÃøÁö¶ó°íµµ Çϸç Hertwig »óÇÇ »Ñ¸®ÁýÀÇ ¿¬°áÀÌ ²÷¾îÁø ºÎÀ§¿¡¼­ »ó¾ÆÁú ¸ð¼¼Æ÷°¡ À¯µµµÇÁö ¾Ê¾Æ »ý±â´Â °ÍÀ¸·Î Ç÷°ü°ú ½Å°æÀÌ ºÐÆ÷ÇØ¼­ ÀÓ»óÀûÀ¸·Î Áß¿äÇÑ ºÎÀ§.
  • lateral canthus
    ¿ÜÃø ´« ±¸¼®, ¿Ü¾È°¢
  • lateral caval lymph node
    °¡ÂÊ ¾Æ·¡ ´ëÁ¤¸Æ ¸²ÇÁÀý
  • lateral cerebral fissure
    ¿ÜÃø ´ë³ú ¿­, ¿ÜÃø±¸
  • lateral cervical fistula
    Ãø°æ·ç
  • lateral chain
    Ãø¼â
  • lateral circumflex femoral artery
    ¿ÜÃø ´ëÅð ȸ¼± µ¿¸Æ
  • lateral collateral ligament
    °¡ÂÊ °ç Àδë
  • lateral compensating curvature
    Ãø¹æ º¸»ó¼º ¸¸°î
    ÇÏ¾Ç ±¸Ä¡°¡ ³»ÃøÀ¸·Î °æ»çµÇ¾î ¸¸°îÀ» ÀÌ·ç´Â °Í.
  • lateral condylar inclination
    Ãø¹æ °ú·Î °æ»ç
    Ãø¹æ °ú·ÎÀÇ ¹æÇâÀÌ´Ù. Ãø¹æ ÇϾǰñ ¿îµ¿½Ã °úµÎ°¡ ¿òÁ÷ÀÎ °æ»çÀÌ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
central osteitis <pathology> Inflammation of bone caused by a pyogenic organism. It may remain localised or may spread through the bone to involve the marrow, cortex, cancellous tissue and periosteum.
Origin: Gr. Myelos = marrow
(18 Nov 1997)
central palmar space The more medial of the central palmar spaces, bounded medially by the hypothenar compartment; related distally to the synovial tendon sheaths of digits 3 and 4 and proximally to the common flexor sheath.
Synonym: medial midpalmar space, middle palmar space.
(05 Mar 2000)
central paralysis Paralysis due to a lesion in the brain or spinal cord.
(05 Mar 2000)
central pit A depression in the centre of the macula retinae containing only cones and lacking blood vessels.
Synonym: fovea centralis retinae, central pit.
(05 Mar 2000)
central placenta previa Placenta previa in which the placenta entirely covers the internal os of the cervix.
Synonym: central placenta previa, total placenta previa.
(05 Mar 2000)
central pneumonia A form of pneumonia in which exudation is confined for a time to the central portion of a lobe or the hilar region.
Synonym: core pneumonia.
(05 Mar 2000)
central pontine myelinolysis <neurology> A condition characterised by damage to the myelin (sheath) layer of nerve cells in the pons (brainstem).
The destruction of myelin inhibits the conduction of a nerve impulse along a nerve cell. The most common cause for exacerbating this condition is a rapid correction of hyponatraemia (low blood sodium level). Some conditions such as Wernicke-Korsakoff syndrome and alcoholism can predispose to loss of myelin.
Symptoms can include weakness, double vision, muscle spasms, speech difficulty, delirium, sleepiness, hallucinations, tremors and uncontrolled eye movements. An MRI scan of the brain can demonstrate the abnormality. A more slow controlled correction of serum sodium levels is necessary in these patients. There is no definitive treatment for the underlying disorder.
(12 Jan 1998)
central Recklinghausen's disease type II type 1 neurofibromatosis
central retinal artery occlusion <ophthalmology> The sudden blockage of the retinal artery with a blood clot that commonly leads to a painless but irreversible blindness in that eye.
(12 Jan 1998)
central retinal fovea A depression in the centre of the macula retinae containing only cones and lacking blood vessels.
Synonym: fovea centralis retinae, central pit.
(05 Mar 2000)
central retinal vein occlusion <ophthalmology> The sudden blockage of the retinal vein with blood clot that commonly leads to a painless irreversible blindness in that eye.
(12 Jan 1998)
central scotoma A scotoma involving the fixation point.
(05 Mar 2000)
central serous choroidopathy Detachment of the sensory retina induced by decreased adhesion between cells of the retinal pigment epithelium which permits plasma from the choriocapillaris to enter subretinal space.
Synonym: central angiospastic retinopathy, central serous retinopathy.
(05 Mar 2000)
central serous retinopathy Detachment of the sensory retina induced by decreased adhesion between cells of the retinal pigment epithelium which permits plasma from the choriocapillaris to enter subretinal space.
Synonym: central angiospastic retinopathy, central serous retinopathy.
(05 Mar 2000)
central sleep apnoea <neurology> A form of sleep apnoea which from the lack of neurologic stimulation to breathe.
(12 Jan 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 15
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 15
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 15
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 15
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 15
ÅëÇÕ°Ë»ö ¿Ï·á